Posted Nov. 17, 2011 at 6:48 a.m.

Premium Lock GSK diabetes drug fails first phase 3 trial

Published: 2011-11-17 06:48:04
Updated: 2011-11-17 06:48:04

GSK GSK

If the pharmaceutical giant can take solace in anything from the results so far, it's that the drug appeared to have no serious side effects. Seven more trials are planned....

Read More
Read More

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll